| Autor: |
Bauer S; Sebastian Bauer, MD, Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany, DKTK Partner Site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany; Jonathan A. Fletcher, MD, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Daniel Rauh, PhD, Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany, Drug Discovery Hub Dortmund (DDHD) am Zentrum für Integrierte Wirkstoffforschung (ZIW), Dortmund, Germany; Johanna Falkenhorst, MD, Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany, DKTK Partner Site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany; and Thomas Mühlenberg, PhD, Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany, DKTK Partner Site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany., Fletcher JA; Sebastian Bauer, MD, Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany, DKTK Partner Site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany; Jonathan A. Fletcher, MD, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Daniel Rauh, PhD, Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany, Drug Discovery Hub Dortmund (DDHD) am Zentrum für Integrierte Wirkstoffforschung (ZIW), Dortmund, Germany; Johanna Falkenhorst, MD, Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany, DKTK Partner Site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany; and Thomas Mühlenberg, PhD, Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany, DKTK Partner Site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany., Rauh D; Sebastian Bauer, MD, Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany, DKTK Partner Site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany; Jonathan A. Fletcher, MD, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Daniel Rauh, PhD, Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany, Drug Discovery Hub Dortmund (DDHD) am Zentrum für Integrierte Wirkstoffforschung (ZIW), Dortmund, Germany; Johanna Falkenhorst, MD, Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany, DKTK Partner Site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany; and Thomas Mühlenberg, PhD, Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany, DKTK Partner Site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany., Falkenhorst J; Sebastian Bauer, MD, Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany, DKTK Partner Site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany; Jonathan A. Fletcher, MD, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Daniel Rauh, PhD, Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany, Drug Discovery Hub Dortmund (DDHD) am Zentrum für Integrierte Wirkstoffforschung (ZIW), Dortmund, Germany; Johanna Falkenhorst, MD, Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany, DKTK Partner Site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany; and Thomas Mühlenberg, PhD, Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany, DKTK Partner Site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany., Mühlenberg T; Sebastian Bauer, MD, Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany, DKTK Partner Site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany; Jonathan A. Fletcher, MD, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Daniel Rauh, PhD, Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany, Drug Discovery Hub Dortmund (DDHD) am Zentrum für Integrierte Wirkstoffforschung (ZIW), Dortmund, Germany; Johanna Falkenhorst, MD, Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany, DKTK Partner Site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany; and Thomas Mühlenberg, PhD, Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany, DKTK Partner Site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany. |
